The estimated Net Worth of Nikita Shah is at least 5.68 百万$ dollars as of 14 August 2024. Ms. Shah owns over 100,000 units of Amneal Pharmaceuticals Inc stock worth over 2,438,328$ and over the last 7 years she sold AMRX stock worth over 1,955,900$. In addition, she makes 1,285,350$ as Chief Human Resource Officer、 Senior Vice President at Amneal Pharmaceuticals Inc.
Sign up
Ms. Shah AMRX stock SEC Form 4 insiders trading
Nikita has made over 16 trades of the Amneal Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she sold 100,000 units of AMRX stock worth 775,000$ on 14 August 2024.
The largest trade she's ever made was exercising 111,060 units of Amneal Pharmaceuticals Inc stock on 1 March 2024 worth over 928,462$. On average, Nikita trades about 25,924 units every 95 days since 2018. As of 14 August 2024 she still owns at least 291,666 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Ms. Shah stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Nikita Shah biography
Nikita Shah serves as Chief Human Resource Officer, Senior Vice President of the Company. Nikita has served as our Senior Vice President, Chief Human Resources Officer since the Combination, and from January 2014 to the completion of the Combination, as Senior Vice President, Corporate Affairs & Human Resources of Amneal. Ms. Shah oversees human resources for the Company. Prior to joining Amneal, Ms. Shah led the internal audit and human resources functions for Warner Chilcott, a global specialty pharmaceutical company, from 2007 to 2014. She also supported corporate M&A, process improvements and systems efficiencies across the organization.
What is the salary of Nikita Shah?
As the Chief Human Resource Officer、 Senior Vice President of Amneal Pharmaceuticals Inc, the total compensation of Nikita Shah at Amneal Pharmaceuticals Inc is 1,285,350$. There are 2 executives at Amneal Pharmaceuticals Inc getting paid more, with Andrew Boyer having the highest compensation of 3,113,080$.
How old is Nikita Shah?
Nikita Shah is 42, she's been the Chief Human Resource Officer、 Senior Vice President of Amneal Pharmaceuticals Inc since 2018. There are 22 older and no younger executives at Amneal Pharmaceuticals Inc. The oldest executive at Amneal Pharmaceuticals Inc is Shlomo Yanai, 67, who is the Independent Director.
What's Nikita Shah's mailing address?
Nikita's mailing address filed with the SEC is C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BLVD., BRIDGEWATER, NJ, 08807.
Insiders trading at Amneal Pharmaceuticals Inc
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over 867,197,480$ worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth 12,997,905$ . The most active insiders traders include Gp A, Llcbonderman Davidcou...、Holdings, Llc Aphc、International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of 3,857,739$. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth 491,654$.
What does Amneal Pharmaceuticals Inc do?
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
What does Amneal Pharmaceuticals Inc's logo look like?
Complete history of Ms. Shah stock trades at Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc executives and stock owners
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Andrew Boyer,
Executive Vice President - Commercial Operations -
Chintu Patel R.Ph, R.Ph.,
Co-Founder, Co-CEO & Director -
Nikita Shah,
Chief Human Resource Officer, Senior Vice President -
Andrew S. Boyer,
Exec. VP & Chief Commercial Officer of Generics -
Anastasios G. Konidaris,
Exec. VP & CFO -
Joseph Todisco MBA,
Exec. VP & Chief Commercial Officer of Specialty -
Nikita Shah,
Exec. VP and Chief HR Officer & Strategic Planning Officer -
J. Kevin Buchi,
Independent Director -
Ted Nark,
Independent Director -
Emily Alva,
Independent Director -
Gautam Patel,
Director -
Chintu Patel,
Co-Chief Executive Officer, Co-Founder, Director -
Chirag Patel,
President, Co-Chief Executive Officer, Director -
Paul Meister,
Independent Chairman of the Board -
Shlomo Yanai,
Independent Director -
John Kiely,
Independent Director -
Jeffrey George,
Independent Director -
Chintu Patel R.Ph., R.Ph,
Co-Founder, Co-CEO & Director -
Chirag K. Patel,
Co-Founder, Co-CEO, Pres & Director -
Joseph Todisco,
Senior Vice President - Specialty Commercial -
Apurva Saraf,
Senior Vice President - Corporate Development -
Joseph Greer,
Senior Vice President - Global Quality Management -
Stephen Manzano,
Senior Vice President, General Counsel & Corporate Secretary -
Sanjay Jain,
President - India -
Anastasios Konidaris,
Chief Financial Officer, Senior Vice President -
Jason B. Daly Esq.,
Sr. VP, Chief Legal Officer & Corp. Sec. -
Dr. Nikunj Patel,
Head of Ops & Exec. VP of Amneal Pharmaceuticals (India) Pvt Ltd -
Sanjiv Patel,
Sr. VP of Operations -
Stephen J. Manzano,
Sr. VP, Gen. Counsel & Corp. Sec. -
Anthony DiMeo,
Sr. Director of Investor Relations -
Sheldon Hirt,
SVP, GC & Corp. Sec. -
Jean Selden Greene,
Director -
Holdings, Llc Aphc,
10% owner -
Robert L Burr,
Director -
Bryan M. Reasons,
CFO -
Robert A Stewart,
President and CEO -
Dharmendra Rama,
Director -
Janet S. Vergis,
Director -
Peter R Terreri,
Director -
Paul Bisaro,
Executive Chairman -
David A Buchen,
SVP, Chief Legal Officer -
Todd P. Branning,
SVP and CFO -
Pradeep Bhadauria,
SVP, Chief Scientific Officer -
International Ltd Fosun,
10% owner -
Gustavo Pesquin,
See Remarks -
Gp A, Llcbonderman Davidcou...,
-
Tasos Konidaris,
Executive Vice President & CFO -
Jason B. Daly,
SVP, Chief Legal Officer -
Deborah M. Autor,
Director -
Dipan Patel,
-
Tushar Bhikhubhai Patel,
10% owner